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Staudinger/aza-Wittig reaction to access
Nβ-protected amino alkyl isothiocyanates†
L. Santhosh, S. Durgamma, Shekharappa and Vommina V. Sureshbabu *
A uniﬁed approach to access Nβ-protected amino alkyl isothiocyanates using Nβ-protected amino alkyl
azides through a general strategy of Staudinger/aza-Wittig reaction is described. The type of protocol
used to access isothiocyanates depends on the availability of precursors and also, especially in the amino
acid chemistry, on the behavior of other labile groups towards the reagents used in the protocols; fortu-
nately, we were not concerned about both these factors as precursor-azides were prepared easily by
standard protocols, and the present protocol can pave the way for accessing title compounds without
aﬀecting Boc, Cbz and Fmoc protecting groups, and benzyl and tertiary butyl groups in the side chains.
The present strategy eliminates the need for the use of amines to obtain title compounds and thus, this
method is step-economical; additional advantages include retention of chirality, convenient handling and
easy puriﬁcation. A few hitherto unreported compounds were also prepared, and all ﬁnal compounds were
completely characterized by IR, mass, optical rotation, and 1H and 13C NMR studies.
Introduction
Isothiocyanates are an important class of compounds and a
focus of interest in contemporary organic chemistry owing to
their wide range of biological activities1 and uses as potential
precursors for accessing thioamides,2 thioureas3 and various
heterocyclic compounds.4 On the application part, based on
structural desirabilities of the final compounds, various iso-
thiocyanates having diﬀerent skeletal structures are used.
Isothiocyanates are most commonly synthesized from
amines, isonitriles and azides (Fig. 1). Thiophosgene upon
thiocarbonyl (CvS) transfer to amines yields isothiocyanates
in excellent yields;5a–d however, its toxicity and intolerance
towards other sensitive functional groups limits its use. Thus,
various CvS transfer reagents have been found to be ideal
replacements for thiophosgene to access isothiocyanates.5e–h
Isothiocyanates are also accessed by the addition of carbon di-
sulfide (CS2) to amines in the presence of a base to form
dithiocarbamate salts, which on in situ desulfurization lead to
the formation of isothiocyanates. Till date, various desulfuriz-
ing agents for dithiocarbamate have been reported in the
literature.6
Synthesis of isothiocyanates from amines, however, faces
few setbacks as most CvS transfer reagents are not readily
available, and there is also the possibility of contamination by
the formation of thioureas. In case of desulfurization of dithio-
carbamate salts, electrophillic desulfurizing agents react with
residual amines to hinder the reaction.
There are reports where isonitriles are reacted with elemen-
tal sulfur via catalytic sulfuration to yield the corresponding
isothiocyanates.7a–d Boyer and Ramakrishnan demonstrated
sulfuration of isonitriles using elemental sulfur and aryl iso-
thiocyanates.7e Furthermore, the synthesis of isothiocyanates
was demonstrated using isocyanates,8 nitrile oxides and hydro-
ximoyl chlorides,9 nitroalkanes,10 aldoximes,11 and alkenes
and alkyl halides.12 Burkett et al. demonstrated ‘catch and
release’ strategies from polymer-bound thiobenzophenone13a
and polymer-bound thiocarbonate13b to realize the synthesis
of isothiocyanates.
The Staudinger reaction is the reaction of an azide with tri-
phenylphosphine (PPh3) to form iminophosphorane with the
Fig. 1 Selected protocols for the synthesis of isothiocyanates.
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evolution of nitrogen gas.14 These iminophosphoranes can be
further used as intermediates to access a wide variety of nitro-
gen-containing organic compounds via the aza-Wittig reac-
tion.15 As a result, the Staudinger/aza-Wittig reaction was
exploited soon after its discovery.16 One such application is the
synthesis of isothiocyanates from the reaction of iminophos-
phorane with CS2, and this is well established as considerable
amount of reports are available for the same.16d–h It is note-
worthy that azaylides are also prepared by the reaction of tri-
phenylphosphinedihalides with amines.17
The realm of peptidomimetics is rapidly advancing owing
to the easy access and application of amino acid-derived pre-
cursors.18 Likewise, amino acid-derived isothiocyanates are
deemed necessary precursors for various peptidomimetic
achievements; they are employed to access thiourea-,19 seleno-
urea-,20a guanidine and carbodiimide-20b and oxadiazole-
tethered peptidomimetics.20c
Most commonly, the isothiocyanato group can be inserted
into amino acid at the N-terminal (α-isothiocyanato alkyl
esters, Fig. 2a) or C-terminal (Nβ-protected amino alkyl isothio-
cyanates, Fig. 2b). Despite the importance of amino acid
derived isothiocyanates, literature records regarding their syn-
thesis are limited. This is understandable as the generalization
of most aforementioned reagents to amino acid chemistry
fails, and the availability of amino acid-derived precursors for
isothiocyanates is limited. Furthermore, undesired reactivities
of sensitive groups, steric factors of side chains and possible
racemization are the major concerns while synthesizing amino
acid-derived isothiocyanates.
A few reports are available on α-isothiocyanato alkyl esters,
and they involve thiocarbonylation of α-amino alkyl esters by
thiophosgene5b–d,21a,b and desulfurization of dithiocarbamate
salts.6b,20,21c–e
Interestingly, protocols for Nβ-protected amino alkyl isothio-
cyanates are very scant in the literature. In fact, the only avail-
able report to access these compounds was provided by our
laboratory.19 Isothiocyanates were prepared by the dithiocarba-
mate pathway from the corresponding amines by employing tosyl
chloride (TsCl) as the desulfurizing agent. Nβ-Fmoc-amino
alkylamines were obtained by the reduction of the corres-
ponding azides using Pd–C/H2. On the other hand, N
β-Boc/
Cbz-amino alkylamines were obtained by the reduction of the
corresponding α-aminonitriles using lithium aluminium
hydride (LiAlH4). Hence, our previous protocol to access N
β-
protected amino alkyl isothiocyanates employed two diﬀerent
routes while employing water sensitive LiAlH4 and expensive
Pd–C catalyst. Furthermore, the syntheses of Nβ-Boc/Cbz-
amino alkyl isothiocyanates and Nβ-Fmoc-amino alkyl isothio-
cyanates from the corresponding Nα-protected amino acids
were 5- and 6-step procedures, respectively (Scheme 1a).
Recently, Bag and De demonstrated the synthesis of side-chain
isothiocyanyl amino acid derivatives by employing a similar
protocol.22 Therein, isothiocyanates were obtained after con-
verting azides to amines, which emphasized the necessity of
using amines.
The dearth of literature regarding accessing Nβ-protected
amino alkyl isothiocyanates drove us to adopt an ad hoc
approach. It was found that the Staudinger/aza-Wittig reaction
was successfully employed to obtain sugar isothiocyanates
from sugar azides.16f However, the application of the reaction
for obtaining amino acid-derived isothiocyanates is yet to be
explored. Furthermore, the type of protocol to be employed
depends on the availability of precursors; luckily, Nβ-Boc/Cbz/
Fmoc-protected alkyl azides were accessed easily by employing
reported protocols, where Nα-protected amino acids were con-
Fig. 2 (a) α-Isothiocyanato alkyl esters and (b) Nβ-protected amino
alkyl isothiocyanates.
Scheme 1 Enantiopure synthesis of Nβ-protected amino alkyl isothiocyanates: (a) the only protocol reported employing two separate routes and
(b) the present uniﬁed approach.
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verted to Nβ-protected amino alkyl iodides, which on azidolysis
gave the corresponding azides.19,23 Thus, Nβ-protected amino
alkyl isothiocyanates were prepared without the need for
corresponding amines, thus making the present protocol step-
economical. Thus, herein, we describe an improved and
unified approach for accessing Nβ-protected amino alkyl
isothiocyanates via the Staudinger/aza-Wittig reaction
(Scheme 1b).
In a typical experiment, to a solution of Cbz-Phg-ψ[CH2N3]
(1a, 1.0 mmol) in dry THF, PPh3 (1.1 mmol) was added, and
the solution was stirred at rt for 4 h. The progress of the entire
reaction was monitored by thin layer chromatography (TLC).
After consumption of the azide, CS2 (10.0 mmol) was added
and stirred at rt for 8 h to aﬀord the corresponding isothio-
cyanate Cbz-Phg-ψ[CH2NCS] (2a) in 91% yield after column
purification. Excess CS2 was used to ensure that the reaction
did not suﬀer from the formation of the corresponding sym-
metrical carbodiimide, and THF was chosen as the solvent as
it was found that various Nβ-protected amino alkyl azides were
completely soluble in it. As we were concerned about the pro-
longed reaction durations, we repeated the experiment under
reflux condition. It was found that 1a completely reacted with
PPh3 to form iminophosphorane within 30 min. The reflux
was continued after the addition of CS2, and it was found to be
highly eﬀective as the corresponding isothiocyanate formation
was completed in an hour to aﬀord 90% yield. Therefore, the
reflux condition was preferred for further preparation of
Nβ-protected alkyl isothiocyanates. Though the reactions in di-
chloromethane (DCM) and 1,4-dioxane were tested and found
as productive as that in THF, the low boiling point of DCM
deterred us from its further use in reflux conditions; on the
other hand, due to its high boiling point, it was diﬃcult
to remove 1,4-dioxane from the reaction mixture, especially
during large-scale synthesis. Various Nβ-protected alkyl azides
were easily converted to the corresponding isothiocyanates to
give good yields of the products (Scheme 2, entries 2a–k).
Fmoc, Boc and Cbz protecting groups showed absolute com-
patabilities with the present strategy as the reaction was
carried out in neutral conditions. The sterically hindered
proline showed facile formation of isothiocyanate from the
corresponding azide (Scheme 2, entry 2g). Compound 2e was
obtained from large-scale synthesis (2.7 g, 11.5 mmol of
azide), and the yield was found to be equally productive as that
at small-scale. The purification of isothiocyanates was easy as
they were relatively non-polar compared to triphenylphosphine
disulfide, as the presence of triphenylphosphine disulfide
resulted in diﬃculties during column purifications. To demon-
strate the proficiency of the protocol, few Nβ-protected alkyl
azides with side chain protections were studied, and good
yields of the products were obtained without aﬀecting the side
chain protections. Tertiary butyl and benzyl groups in the side
chains were not aﬀected at all (Table 1, entries 2l–o).
It is important to note that the reaction was not inhibited
by the presence of a side chain as bulky as in compound 2p.
The compatibilities of these compounds towards the present
strategy were reflected in the isolated yields (Table 1, entries
2l–p). During the process, we also prepared few hitherto un-
reported compounds (Scheme 2, entry 2g and Table 1, entries
2l–p), and all final compounds were completely characterized
by IR, mass, melting point, optical rotation, and 1H and 13C
NMR studies. The synthesized compounds were subjected to
RP-HPLC analysis, and good purity was observed.
The syntheses of Nβ-protected alkyl isothiocyanates from
the corresponding azides were carried out in neutral con-
ditions. Racemization studies were carried out to confirm the
validity of the protocol, during which compound 2a was
coupled with (R)-1-phenylethylamine and (S)-1-phenylethyl-
amine separately to obtain the corresponding compounds 3a
and 3a* (Fig. 3). RP-HPLC analyses showed a retention time
(tR) of 14.28 min for 3a, whereas the tR value of 3a* was
12.67 min.
Moreover, equimolar mixtures of 3a and 3a* showed reten-
tion times of 14.86 min and 12.79 min, respectively.
Furthermore, 1H NMR spectra of 3a and 3a* showed doublets
Table 1 Few side chain protected Nβ-protected amino alkyl
isothiocyanates
Scheme 2 Synthesis of Nβ-protected amino alkyl isothiocyanates from
Nβ-protected amino alkyl azides.
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at δ 1.46 and 1.42, respectively, which corresponded to the
methyl protons of each epimer. These analyses provided
unequivocal evidence for racemization-free synthesis of the
title compounds.
Conclusions
The Staudinger/aza-Wittig reaction was employed as an ad hoc
approach for obtaining Nβ-protected alkyl isothiocyanates from
their corresponding azides. The protocol was an improved and
unified version of our previous protocol for achieving the same
products. It shall be the preferred choice considering that the
precursor azides were easily accessible and most importantly,
it eliminated the need for the use of amines to obtain isothio-
cyanates, due to which the protocol is step-economical and
cost-eﬀective. The neutral reaction condition benefitted the
achievement of racemization-free synthesis of the title com-
pounds bearing acid- and base-sensitive moieties.
Experimental section
General experimental details
All chemicals were used as obtained from Sigma Aldrich
Company, USA. All solvents were dried and purified using pro-
cedures recommended in the literature whenever necessary.
High-resolution mass spectra were recorded on a Micromass
Q-TOF spectrometer. 1H-NMR and 13C-NMR spectra were
recorded on Bruker AV NMR 400 MHz and 100 MHz spec-
trometers, respectively. The RP-HPLC analysis of epimers was
carried out using an Agilent instrument (method: gradient 0.1%
TFA water-acetonitrile (0–100%) in 30 min; VWD at λ = 254 nm;
flow rate: 1.0 mL min−1; column: Agilent Eclipse, XDB-C18, pore
size 5 μm, diameter × length = 4.6 × 150 nm). Optical rotations
of the compounds were recorded at 25 °C; melting points were
determined in an open capillary and were uncorrected. TLC
experiments were performed using MERCK TLC aluminum
sheets (silica gel 60 F254), and chromatograms were visualized
with exposure to an iodine chamber, UV-lamp or KMnO4 stain.
Column chromatography was performed on silica gel
(100–200 mesh) using ethylacetate and hexane (obtained from
Merck and distilled and dried prior to use) mixtures as eluents.
General procedure for the synthesis of Nβ-protected amino
alkyl azides from Nα-protected amino acid
To a solution of Nα-protected amino acid (1.0 equiv.) in THF at
−15 °C, N-methylmorpholine (NMM, 1.0 equiv.) and ethyl-
chloroformate (ECF, 1.0 equiv.) were added, and the solution
was stirred at the same temperature for 15 min. The inorganic
salts were filtered oﬀ, and the filtrate was treated with moist
NaBH4 (2.0 equiv.) for 30 min. Excess water was added and
stirred for 15 min. THF was removed by vacuum evaporation,
and the resultant solution was extracted with EtOAc and
washed with 10% Na2CO3, 10% citric acid, and brine; it was
then dried over Na2SO4. The solvent was evaporated under
reduced pressure. The resultant compound without prior puri-
fication was used in the next step.
In the next step, a solution of Nβ-protected aminol (1.0
equiv.) in CH2Cl2 was added to a stirred mixture of PPh3 (3.0
equiv.), imidazole (5.0 equiv.) and iodine (3.0 equiv.) in dry
CH2Cl2. After 6 h, the reaction mixture was evaporated, and
the crude product was subjected to flash chromatography
using 10% ethyl acetate in hexane as eluent to aﬀord the
corresponding Nβ-protected amino alkyl iodide.
Then, to the solution of Nβ-protected amino alkyl iodide
(1.0 equiv.) in DMF, sodium azide (1.5 equiv.) was added, and
the solution was stirred for 6 h at rt. The corresponding amino
alkyl azide 1 was obtained in good yield and purity after
aqueous workup.
General procedure for the synthesis of Nβ-protected alkyl
isothiocyanates from Nβ-protected alkyl azides (2a–p)
To a stirred solution of Nβ-protected alkyl azide (1.0 equiv.) in
dry THF, PPh3 (1.1 equiv.) was added, and the solution was
refluxed for 30 min. After the consumption of azide (by TLC),
CS2 (10.0 equiv.) was added and refluxed for another hour. The
solvent was evaporated under reduced pressure, and the
obtained residue was subjected to column chromatography to
isolate the corresponding isothiocyanate in good yield.
General procedure for preparing thiourea derivatives (3a and
3a*)
To a stirred solution of 2a (1.0 equiv.) in THF, (R)-1-phenyl-
ethylamine (or (S)-1-phenylethyamine, 1.1 equiv.) was added,
and the solution was stirred for 2 h at rt. The solvent was
vacuum-evaporated and diluted with EtOAc, washed with 5%
citric acid (2 × 10 mL), water (2 × 10 ml) and brine (10 mL),
and dried over Na2SO4. The worked-up compound solution
was vacuum-evaporated to obtain 3a (or 3a*) in good yield and
purity.
Cbz-Phg-ψ[CH2NCS] (2a). White solid (90% yield);
m.p. 131–133 °C; [α]25D (c 1.0, CHCl3) +12.0; IR (νmax cm
−1):
2200, 2096, 1686; 1H-NMR (400 MHz, CDCl3) δ 7.25–7.41 (m,
10H), 5.33 (d, J = 8Hz, 1H), 5.13 (dd, J = 20 Hz, 12 Hz, 2H),
4.96–5.02 (br m, 1H), 3.82–3.92 (br m, 2H); 13C-NMR
(100 MHz, CDCl3) δ 155.5, 137.5, 135.9, 133.7, 129.1, 128.6,
128.5, 128.2, 128.1, 126.4, 67.3, 54.9, 49.7; HRMS (ESI): m/z
calcd for C17H16N2O2SNa [M + Na]
+ 335.0830, found: 335.0832.
Cbz-Ala-ψ[CH2NCS] (2b). White solid (92% yield);
m.p. 112–114 °C; [α]25D (c 1.0, CHCl3) −97.3; IR (νmax cm
−1):
2204, 2092, 1686; 1H-NMR (400 MHz, CDCl3) δ 7.26–7.37 (m,
5H), 5.07–5.15 (m, 2H), 4.83 (br s, 1H), 3.97 (br m, 1H), 3.72
(d, J = 12 Hz, 1H), 3.56 (dd, J = 12 Hz, 4 Hz, 1H), 1.27 (d, J = 8
Fig. 3 Epimeric thiourea derivatives.
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Hz, 3H); 13C-NMR (100 MHz, CDCl3) δ 155.4, 136.1, 132.8,
128.6, 128.3, 128.1, 67.0, 50.1, 46.9, 17.9; HRMS (ESI): m/z
calcd for C12H14N2O2SNa [M + Na]
+ 273.0674, found: 273.0677.
Cbz-Phe-ψ[CH2NCS] (2c). White solid (86% yield);
m.p. 126–128 °C; [α]25D (c 1.0, CHCl3) −22.6; IR (νmax cm
−1):
2206, 2104, 1697; 1H-NMR (400 MHz, CDCl3) δ 7.18–7.36 (m,
10H), 5.10 (s, 2H), 4.93 (d, J = 8 Hz, 1H), 4.09 (br m, 1H), 3.68
(dd, J = 12 Hz, 4 Hz, 1H), 3.50 (dd, J = 16 Hz, 4 Hz, 1H), 2.95
(dd, J = 12 Hz, 8 Hz, 1H), 2.84 (dd, J = 16 Hz, 8 Hz, 1H);
13C-NMR (100 MHz, CDCl3) δ 155.4, 138.2, 136.0, 133.3, 129.1,
128.9, 128.6, 128.3, 128.1, 127.7, 67.1, 52.1, 47.3, 37.8; HRMS
(ESI): m/z calcd for C18H18N2O2SNa [M + Na]
+ 349.0987, found:
349.0986.
Cbz-Gly-ψ[CH2NCS] (2d). Oily liquid (90% yield) IR
(νmax cm
−1): 2195, 2101, 1696; 1H-NMR (400 MHz, CDCl3)
δ 7.26–7.37 (m, 5H); 5.21 (s, 1H), 5.12 (s, 2H), 3.65 (t, J = 8 Hz,
2H), 3.41–3.46 (m, 2H); 13C-NMR (100 MHz, CDCl3) δ 156.2,
136.1, 132.8, 128.6, 128.3, 128.2, 67.1, 45.3, 41.0; HRMS (ESI):
m/z calcd for C11H12N2O2SNa [M + Na]
+ 259.0517, found:
259.0518.
Cbz-β-Ala-ψ[CH2NCS] (2e). White solid (89% yield);
m.p. 55–57 °C; IR (νmax cm
−1): 2184, 2099, 1692; 1H-NMR
(400 MHz, CDCl3) δ 7.26–7.39 (m, 5H), 5.10 (s, 2H), 4.90 (br s,
1H), 3.59 (t, J = 8 Hz, 2H), 3.30–3.34 (m, 2H), 1.90–1.93 (m,
2H); 13C-NMR (100 MHz, CDCl3) δ 156.4, 136.3, 132.3, 128.5,
128.2, 128.1, 66.9, 42.6, 38.2, 30.2; HRMS (ESI): m/z calcd for
C12H14N2O2SNa [M + Na]
+ 273.0674, found: 273.0677.
Cbz-Leu-ψ[CH2NCS] (2f). White solid (91% yield);
m.p. 106–108 °C; [α]25D (c 1.0, CHCl3) −112.0; IR (νmax cm
−1):
2172, 2103, 1694; 1H-NMR (400 MHz, CDCl3) δ 7.31–7.37 (m,
5H), 5.11 (s, 2H), 4.79 (d, J = 4 Hz, 1H), 3.88–3.94 (m, 1H), 3.74
(dd, J = 16 Hz, 4 Hz, 1H), 3.55 (dd, J = 16 Hz, 4 Hz, 1H),
1.62–1.72 (m, 1H), 1.37–1.46 (m, 2H), 0.94 (d, J = 8 Hz, 6H);
13C-NMR (100 MHz, CDCl3) δ 155.6, 136.1, 132.6, 128.5, 128.2,
128.1, 67.0, 49.2, 40.9, 24.7, 22.8, 22.0; HRMS (ESI): m/z calcd
for C15H20N2O2SNa [M + Na]
+ 315.1143, found: 315.1141.
Boc-Pro-ψ[CH2NCS] (2g). Oily liquid (85% yield); [α]25D (c 1.0,
CHCl3) −99.4; IR (νmax cm−1): 2189, 2081, 1687; 1H-NMR
(400 MHz, CDCl3) δ 3.85–3.96 (br m, 2H), 3.60–3.64(m, 1H),
3.37–3.48 (br m, 2H), 2.06–2.13 (m, 1H), 1.83–1.92 (m, 3H),
1.47 (s, 9H), 13C-NMR (100 MHz, CDCl3) δ 154.1, 131.5, 79.9,
56.4, 47.9, 47.1, 28.4, 23.7; HRMS (ESI): m/z calcd for
C11H18N2O2SNa [M + Na]
+ 265.0987, found: 265.0983.
Boc-Phe-ψ[CH2NCS] (2h). White solid (87% yield);
m.p. 106–108 °C; [α]25D (c 1.0, CHCl3) −39.3; IR (νmax cm
−1):
2203, 2113, 1685; 1H-NMR (400 MHz, CDCl3) δ 7.20–7.35 (m,
5H), 4.67 (br s, 1H), 4.02 (br s, 1H), 3.65 (br d, J = 12 Hz, 1H),
3.48 (dd, J = 12 Hz, 8 Hz, 1H), 2.92 (br m, 1H), 2.81 (dd, J =
12 Hz, 8 Hz, 1H), 1.44 (s, 9H); 13C-NMR (100 MHz, CDCl3)
δ 154.9, 136.3, 132.8, 129.1, 128.8, 127.0, 80.1, 51.5, 47.6, 37.9,
28.3; HRMS (ESI): m/z calcd for C15H20N2O2SNa [M + Na]
+
315.1143, found: 315.1141.
Boc-Phg-ψ[CH2NCS] (2i). White solid (88% yield);
m.p. 90–92 °C; [α]25D (c 1.0, CHCl3) +11.0; IR (νmax cm
−1): 2209,
2093, 1681; 1H-NMR (400 MHz, CDCl3) δ 7.26–7.40 (m, 5H),
5.05 (d, J = 12 Hz, 1H), 4.93 (br s, 1H), 3.82–3.92 (m, 2H), 1.46
(s, 9H); 13C-NMR (100 MHz, CDCl3) δ 154.9, 138.0, 133.3,
129.0, 128.5, 126.5, 80.5, 55.6, 49.8, 28.3; HRMS (ESI): m/z
calcd for C14H18N2O2SNa [M + Na]
+ 301.0987, found: 301.0988.
Fmoc-Phe-ψ[CH2NCS] (2j). White solid (89% yield);
m.p. 187–189 °C; [α]25D (c 1.0, CHCl3) −18.1; (νmax cm
−1): 2164,
2097, 1687; 1H-NMR (400 MHz, CDCl3) δ 7.76 (d, J = 8 Hz, 2H),
7.54 (t, J = 8 Hz, 2H), 7.29–7.41 (m, 9H), 4.87 (d, J = 8 Hz, 1H),
4.39 (d, J = 8 Hz, 2H), 4.19 (t, J = 8 Hz, 1H), 4.04 (br s, 1H), 3.44
(br d, J = 8 Hz, 1H), 3.34 (br d, J = 8 Hz, 1H), 2.79–2.84 (br m,
2H); 13C-NMR (100 MHz, CDCl3) δ 155.6, 143.7, 141.3, 136.8,
129.2, 129.0, 128.9, 128.7, 127.7, 127.0, 126.8, 124.9, 119.9,
66.7, 53.1, 51.8, 47.2, 38.0; HRMS (ESI): m/z calcd for
C25H22N2O2SNa [M + Na]
+ 437.1300, found: 437.1303.
Fmoc-Val-ψ[CH2NCS] (2k). White solid (83% yield);
m.p. 164–166 °C; [α]25D (c 1.0, CHCl3) −74.0; IR (νmax cm
−1):
2196, 2011, 1684; 1H-NMR (400 MHz, CDCl3) δ 7.77 (d, J =
8 Hz, 2H), 7.60 (d, J = 8 Hz, 2H), 7.40 (t, J = 8 Hz, 2H), 7.33 (t,
J = 8 Hz, 2H), 4.83 (d, J = 8 Hz, 1H), 4.46 (d, J = 8 Hz, 2H), 4.24
(t, J = 8 Hz, 1H), 3.69–3.75 (m, 2H), 3.55–3.61 (m, 1H),
1.80–1.89 (m, 1H), 0.97 (t, J = 8 Hz, 6H); 13C-NMR (100 MHz,
CDCl3) δ 155.9, 143.7, 141.3, 132.5, 127.7, 127.1, 127.0, 125.0,
124.9, 120.0, 66.7, 56.5, 47.3, 29.4, 19.3, 18.6; HRMS (ESI): m/z
calcd for C21H22N2O2SNa [M + Na]
+ 389.1300, found: 389.1301.
Boc-Tyr(Bzl)-ψ[CH2NCS] (2l). White solid (85% yield);
m.p. 79–81 °C; [α]25D (c 1.0, CHCl3) +19.6; IR (νmax cm
−1): 2202,
2089, 1691; 1H-NMR (400 MHz, CDCl3) δ 7.32–7.43 (m, 5H),
7.12 (d, J = 8 Hz, 2H), 6.93 (d, J = 8 Hz, 2H), 5.05 (s, 2H), 4.65
(br s, 1H), 3.96 (br s, 1H), 3.63 (d, J = 12 Hz, 1H), 3.47 (dd, J =
12 Hz, 8 Hz, 1H), 2.86 (d, J = 8 Hz, 1H), 2.74 (dd, J = 12 Hz,
8 Hz, 1H), 1.44 (s, 9H); 13C-NMR (100 MHz, CDCl3) δ 157.9,
154.9, 136.9, 132.7, 130.1, 128.5, 127.9, 127.4, 115.2, 80.1, 70.0,
51.6, 47.5, 37.0, 28.3; HRMS (ESI): m/z calcd for
C22H26N2O3SNa [M + Na]
+ 421.1562, found: 421.1566.
Fmoc-Tyr(tBu)-ψ[CH2NCS] (2m). Gummy solid (79%
yield); [α]25D (c 1.0, CHCl3) +6.2; IR (νmax cm
−1): 2186, 2096,
1701; 1H-NMR (400 MHz, CDCl3) δ 6.83–7.76 (m, 12H), 4.91 (s,
1H), 4.42 (d, J = 8 Hz, 2H), 4.22 (t, J = 8 Hz, 1H), 4.02–4.10 (br
m, 1H), 3.67 (br d, J = 12 Hz, 1H), 3.48 (br d, J = 12 Hz, 1H),
2.74–2.88 (br m, 2H), 1.33 (s, 9H); 13C-NMR (100 MHz, CDCl3)
δ 155.4, 154.5, 143.6, 141.3, 133.2, 129.5, 128.5, 127.7, 127.1,
124.9, 124.4, 120.0, 78.5, 66.8, 52.1, 47.4, 47.2, 37.0, 28.8;
HRMS (ESI): m/z calcd for C29H30N2O3SNa [M + Na]
+ 509.1875,
found: 509.1873.
Fmoc-Ser(tBu)-ψ[CH2NCS] (2n). White solid (81% yield);
m.p. 86–88 °C; [α]25D (c 1.0, CHCl3) −14.3; IR: (νmax cm
−1): 2119,
2074, 1691; 1H-NMR (400 MHz, CDCl3) δ 7.77 (d, J = 8 Hz, 2H),
7.59 (d, J = 8 Hz, 2H), 7.41 (t, J = 8 Hz, 2H), 7.32 (t, J = 8 Hz,
2H), 5.15 (d, J = 8 Hz, 1H), 4.41 (d, J = 8 Hz, 2H), 4.24 (t, J =
8 Hz, 1H), 3.99 (br s, 1H), 3.65 (br s, 2H), 3.54 (d, J = 8 Hz, 1H),
3.41–3.44 (m, 1H), 1.20 (s, 9H); 13C-NMR (100 MHz, CDCl3)
δ 155.7, 143.8, 141.3, 132.2, 127.7, 127.1, 125.0, 124.9, 120.0,
73.6, 66.9, 59.9, 50.7, 47.2, 45.4, 27.4; HRMS (ESI): m/z calcd
for C23H26N2O3SNa [M + Na]
+ 433.1562, found: 433.1560.
Fmoc-Thr(tBu)-ψ[CH2NCS] (2o). Oily liquid (81% yield); [α]25D
(c 1.0, CHCl3) +9.7; IR (νmax cm
−1): 2194, 2092, 1719; 1H-NMR
(400 MHz, CDCl3) δ 7.76 (d, J = 4 Hz, 2H), 7.60 (d, J = 8 Hz,
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2H), 7.30–7.40 (m, 4H), 5.14 (d, J = 8 Hz, 1H), 4.44 (d, J = 8 Hz,
2H), 4.25 (t, J = 8 Hz, 1H), 3.87 (br d, J = 4 Hz, 1H), 3.70–3.80
(br m, 1H), 3.54–3.58 (m, 2H), 1.22 (t, J = 16 Hz, 12H);
13C-NMR (100 MHz, CDCl3) δ 156.1, 143.8, 141.3, 131.8, 127.7,
127.0, 125.0, 124.9, 119.9, 74.2, 66.9, 64.9, 55.9, 47.2, 45.7,
28.7, 20.3; HRMS (ESI): m/z calcd for C24H28N2O3SNa [M + Na]
+
447.1718, found: 447.1715.
Fmoc-Cys(Trt)-ψ[CH2NCS] (2p). Oily liquid (83% yield);
[α]25D (c 1.0, CHCl3) −13.9; IR (νmax cm−1): 2193, 2091, 1701;
1H-NMR (400 MHz, CDCl3) δ 7.75 (t, J = 8 Hz, 2H), 7.56 (d, J =
8 Hz, 2H), 7.20–7.41 (m, 19H), 4.59 (br s, 1H), 4.40 (d, J = 8 Hz,
2H), 4.19 (t, J = 8 Hz, 1H), 3.52 (br s, 3H), 2.46 (br s, 2H);
13C-NMR (100 MHz, CDCl3) δ 155.3, 144.1, 143.6, 141.3, 133.1,
129.4, 128.1, 128.0, 127.7, 127.0, 124.9, 120.0, 67.4, 66.7, 50.2,
47.7, 47.1, 33.2; HRMS (ESI): m/z calcd for C38H32N2O2S2Na
[M + Na]+ 635.1803, found: 635.1807.
Cbz-Phg-ψ[CH2NHCSNH]-(R)-(+)-1-phenylethylamine (3a).
1H-NMR (400 MHz, CDCl3) δ 7.17–7.34 (m, 15H), 6.60 (br s,
1H), 6.10 (br s, 1H), 5.66 (br s, 1H), 5.06 (dd, J = 16 Hz, 8 Hz,
2H), 4.72–4.76 (br m, 2H), 4.0–4.08 (br m, 1H), 3.69 (br d, J =
8 Hz, 1H), 1.46 (d, J = 8 Hz, 3H); 13C-NMR (100 MHz, CDCl3)
δ 181.6, 156.5, 141.9, 139.0, 136.2, 129.0, 128.5, 128.2 (2C),
128.1, 127.8, 126.4, 125.7, 67.0, 60.3, 56.0, 53.8, 29.7.
Cbz-Phg-ψ[CH2NHCSNH]-(S)-(−)-1-phenylethylamine (3a*).
1H-NMR (400 MHz, CDCl3) δ 7.19–7.27 (m, 15H), 6.57 (br s,
1H), 6.04 (br s, 1H), 5.72 (br s, 1H), 4.97 (s, 2H), 4.63 (br s,
2H), 3.82–3.86 (br m, 1H), 3.71–3.77 (br m, 1H), 1.42 (d, J =
4 Hz, 3H); 13C-NMR (100 MHz, CDCl3) δ 181.5, 156.7, 142.0,
138.8, 136.2, 129.0, 128.5, 128.1, 127.9, 127.8, 126.4, 125.8,
66.8, 55.2, 53.5, 50.4, 23.6.
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